Detalhe da pesquisa
1.
Phase I study of emactuzumab single agent or in combination with paclitaxel in patients with advanced/metastatic solid tumors reveals depletion of immunosuppressive M2-like macrophages.
Ann Oncol
; 30(8): 1381-1392, 2019 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31114846
2.
Surgery in reference centers improves survival of sarcoma patients: a nationwide study.
Ann Oncol
; 30(7): 1143-1153, 2019 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31081028
3.
Survival Benefit of the Surgical Management of Retroperitoneal Sarcoma in a Reference Center: A Nationwide Study of the French Sarcoma Group from the NetSarc Database.
Ann Surg Oncol
; 26(7): 2286-2293, 2019 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-31065964
4.
CHK1 inhibition in soft-tissue sarcomas: biological and clinical implications.
Ann Oncol
; 29(4): 1023-1029, 2018 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29409053
5.
Phase I study of the checkpoint kinase 1 inhibitor GDC-0575 in combination with gemcitabine in patients with refractory solid tumors.
Ann Oncol
; 29(5): 1304-1311, 2018 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29788155
6.
Improving at a nationwide level the management of patients with sarcomas with an expert network.
Ann Oncol
; 33(6): 659-661, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35219775
7.
Aplidin in patients with advanced dedifferentiated liposarcomas: a French Sarcoma Group Single-Arm Phase II study.
Ann Oncol
; 26(7): 1465-70, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-26041763
8.
Retroperitoneal sarcomas: patterns of care in advanced stages, prognostic factors and focus on main histological subtypes: a multicenter analysis of the French Sarcoma Group.
Ann Oncol
; 25(3): 730-734, 2014 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-24496921
9.
Retroperitoneal sarcomas: patterns of care at diagnosis, prognostic factors and focus on main histological subtypes: a multicenter analysis of the French Sarcoma Group.
Ann Oncol
; 25(3): 735-742, 2014 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-24567518
10.
Surgery in reference centers improves survival of sarcoma patients: a nationwide study.
Ann Oncol
; 30(8): 1407, 2019 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31168580
11.
Sclerosing Epithelioid Fibrosarcoma (SEF) versus Low Grade Fibromyxoid Sarcoma (LGFMS): Presentation and outcome in the nationwide NETSARC+ series of 330 patients over 13 years.
Eur J Cancer
; 196: 113454, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38008029
12.
Epithelioid hemangio-endothelioma (EHE) in NETSARC: The nationwide series of 267 patients over 12 years.
Eur J Cancer
; 192: 113262, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37625241
13.
Advanced well-differentiated/dedifferentiated liposarcomas: role of chemotherapy and survival.
Ann Oncol
; 23(6): 1601-7, 2012 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-22039081
14.
Docetaxel rechallenge after a first response in non-resistant metastatic breast cancer: significant activity with manageable toxicity.
Breast Cancer Res Treat
; 134(1): 325-32, 2012 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-22531859
15.
Patterns of care and outcomes of 417 patients with METAstatic SYNovial sarcoma (METASYN): real-life data from the French Sarcoma Group (FSG).
ESMO Open
; 7(2): 100402, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35202953
16.
Pembrolizumab in soft-tissue sarcomas with tertiary lymphoid structures: a phase 2 PEMBROSARC trial cohort.
Nat Med
; 28(6): 1199-1206, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35618839
17.
Searching for aurora in the night of sarcoma phase II trials: isn't it time to move to second gear?
Ann Oncol
; 27(10): 1815-7, 2016 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27502727
18.
A review of PARP inhibitors: from bench to bedside.
Ann Oncol
; 22(2): 268-79, 2011 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-20643861
19.
Pulmonary sarcoidosis induced by the anti-PD1 monoclonal antibody pembrolizumab.
Ann Oncol
; 27(6): 1178-1179, 2016 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-27091806
20.
Expression and prognostic significance of PDGF ligands and receptors across soft tissue sarcomas.
ESMO Open
; 6(1): 100037, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33524869